Research published just this month (December 2015) from France has found markers for the diseases of Multiple Chemical Sensitivity (MCS) and Electro-Hypersensitivity (EHS) that can be found through testing that is already available. The patients evaluated for this study showed increased signs of inflammation and oxidative stress as well as permeability of the blood-brain-barrier (BBB) and reduced blood flow to the thalamus (a part of the brain). 40% of patients had elevated histamine levels. Several chemicals associated with permeability of the BBB were found in 28% and 15% of patients. Circulating autoantibodies against o-myelin were found in 23% of patients which suggests an autoimmune component to these disorders for some people. The reduced blood flow in the brain involves the thalamus and the limbic system. The researchers suggest that both of these conditions (MCS and EHS) probably share a common pathological mechanism. They also suggest this process could be degenerative.
Reliable disease biomarkers characterizing and identifying electrohypersensitivity and multiple chemical sensitivity as two etiopathogenic aspects of a unique pathological disorder
